Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGyre Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Gyre Therapeutics, Inc. Earnings Date And Information
Gyre Therapeutics, Inc. last posted its earnings results on Tuesday, March 26th, 2024. The company reported $-0.6814 earnings per share for the quarter, missing analysts' consensus estimates of $-0.6 by $0.0814. The company had revenue of 25.49 M for the quarter and had revenue of 113.45 M for the year. Gyre Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.41 diluted earnings per share) and currently has a price-to-earnings ratio of -26.41. Gyre Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based on prior year's report dates.
Gyre Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | $0.06 | $25.49 M | |||
| 08/13/2024 | Q2 2024 | $0.04 | $25.23 M | |||
| 03/30/2024 | Q1 2024 | $0.09 | $27.17 M | |||
| 12/30/2023 | Q4 2023 | -$0.68 | $29.98 M | |||
| 10/26/2023 | Q3 2023 | -$0.75 | -$0.68 | 0.07 | $30.74 M | |
| 08/14/2023 | Q2 2023 | $0.15 | $26.14 M | |||
| 05/15/2023 | Q1 2023 | $0.14 | $24.44 M | |||
| 03/30/2023 | Q4 2022 | -$0.06 | $-794,000 | |||
| 11/14/2022 | Q3 2022 | -$0.05 | $29.17 M | |||
| 08/15/2022 | Q2 2022 | $0.08 | $797,000 | $23.33 M | ||
| 05/09/2022 | Q1 2022 | $0.08 | $794,000 | |||
| 03/31/2022 | Q4 2021 | -$0.65 | $2.44 M | |||
| 11/12/2021 | Q3 2021 | -$0.80 | $333,333 | $2.30 M | ||
| 08/05/2021 | Q2 2021 | -$0.64 | $1.07 M | $1.13 M | ||
| 05/06/2021 | Q1 2021 | -$0.79 | $1.47 M | |||
| 03/04/2021 | Q4 2020 | -$0.85 | $2.03 M | |||
| 11/05/2020 | Q3 2020 | -$0.73 | $300,000 | $893,000 | ||
| 08/06/2020 | Q2 2020 | -$0.96 | $7.95 M | $1.66 M | ||
| 05/11/2020 | Q1 2020 | -$0.28 | $16.37 M | |||
| 02/20/2020 | Q4 2019 | -$1.13 | $0 |
Gyre Therapeutics, Inc. Earnings: FAQ's
When is Gyre Therapeutics, Inc.'s earnings date?
Gyre Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based off last year's report dates.
How can I listen to Gyre Therapeutics, Inc.'s earnings conference
call?
The conference call for Gyre Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Gyre Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Gyre Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Gyre Therapeutics, Inc. generate each year?
Gyre Therapeutics, Inc. (:GYRE) has a recorded annual revenue of $113.45 M.
How much profit does Gyre Therapeutics, Inc. generate each year?
Gyre Therapeutics, Inc. (:GYRE) has a recorded net income of $113.45 M. Gyre Therapeutics, Inc. has generated $-1.41 earnings per share over the last four quarters.
What is Gyre Therapeutics, Inc.'s price-to-earnings ratio?
Gyre Therapeutics, Inc. (:GYRE) has a price-to-earnings ratio of -26.41 and price/earnings-to-growth ratio is -0.44.